When Targeting Cancer Genes, Zero in on the One Percent
![](https://biosciences.lbl.gov/wp-content/uploads/2016/08/eIF3dmodel750-410x273-150x150-Cate.jpg)
UC Berkeley researchers have found a promising new drug target within the pathway that controls production of a cell’s thousands of proteins. That is appealing, in part, because it appears to control production of only a few percent of the body’s many proteins, those critical to regulating the growth and proliferation of cells. The study was led by Jamie Cate, a faculty scientist in Berkeley Lab’s Molecular Biophysics & Integrated Bioimaging Division. Read more on UC Berkeley News.